Identifying driver mutations involves several advanced techniques in genomics and bioinformatics. Whole-genome sequencing (WGS) and whole-exome sequencing (WES) are commonly used to detect these mutations. Comparative analysis between cancerous and normal tissues helps to distinguish driver mutations from passenger mutations. Additionally, functional assays and computational models are employed to validate the oncogenic potential of these mutations.
